1. CD74–ROS1 L2026M mutant enhances autophagy through the MEK/ERK pathway to promote invasion, metastasis and crizotinib resistance in non‐small cell lung cancer cells
   Xiaobo Xu et al, 2024, The FEBS Journal CrossRef
2. ROS1 rearrangement testing: Is immunohistochemistry changing the horizon?
   Anuradha Choughule et al, 2019, Cancer Research, Statistics, and Treatment CrossRef
3. A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report
   Huiyu Hu et al, 2021, Journal of Medical Case Reports CrossRef
4. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges
   Yuchu Xiang et al, 2024, Frontiers in Immunology CrossRef
5. From Single-Gene to Multiplex Analysis in Lung Cancer, Challenges and Accomplishments: A Review of a Single Institution’s Experience
   Weiqiang Zhao et al, 2014, Lung Cancer Management CrossRef
6. CD44-SLC1A2 Fusion Transcripts in Primary Colorectal Cancer
   Kazuya Shinmura et al, 2015, Pathology & Oncology Research CrossRef
7. Polymorphism of Rs9387478 Correlates with Overall Survival in Female Nonsmoking Patients with Lung Cancer
   Jie-Fei Han et al, 2016, The International Journal of Biological Markers CrossRef
8. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing
   Carol Beadling et al, 2016, The Journal of Molecular Diagnostics CrossRef
9. Emerging Biomarkers in Personalized Therapy of Lung Cancer
   Philip T. Cagle et al, 2016, Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management CrossRef
10. CD74 and HLA-DRA in Cervical Carcinogenesis: Potential Targets for Antitumour Therapy
    Carol K. Balakrishnan et al, 2022, Medicina CrossRef
11. Detection of ROS1 gene fusions using next-generation sequencing for patients with malignancy in China
    Ning Li et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
12. Prognostic and predictive biomarkers in lung cancer. A review
    Erik Thunnissen et al, 2014, Virchows Archiv CrossRef
13. Determination of ROS1 positivity by immunohistochemistry in a multicentric cohort of 426 non-small-cell lung cancer cases in India
    Jugnu Jain et al, 2019, Cancer Research, Statistics, and Treatment CrossRef
14. CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib
    Wenfeng Gou et al, 2018, Cancer Letters CrossRef
15. Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas
    Shivani Sharma et al, 2022, South Asian Journal of Cancer CrossRef
16. A novel somatic FGFR3 mutation in primary lung cancer
    KAZUYA SHINMURA et al, 2014, Oncology Reports CrossRef
17. Testing for ROS1 in non-small cell lung cancer: a review with recommendations
    Lukas Bubendorf et al, 2016, Virchows Archiv CrossRef